Wangda Zhou, PHD

Associate Director Pharmacometrics
Clinical Pharmacology and Pharmacometrics, Johnson and Johnson Innovative Medicine
Spring House, Pennsylvania, United States

Wangda Zhou, Ph.D is an associate scientific director at Clinical Pharmacology and Pharmacometrics within Janssen R&D, US. He is the Pharmacometric team lead responsible for CVM and Retinal therapeutical areas. Wangda has ~10 years of experience applying novel pharmacometric methodologies supporting model informed drug development across multiple therapeutic areas and drug modalities in pharmaceutical industry. Wangda received his PhD in pharmaceutical sciences from University of Connecticut and BS in biology from Fudan University in China.

Presentation(s):

• OC 66.2 - Characterizing the Relationship between Milvexian Exposure, Efficacy, and Safety in Total Knee Replacement Patients to Support Milvexian Phase 3 Dose Selection.

  Tuesday, June 25, 2024
  15:00 – 15:15 ICT